SATELLITE BEACH, FL, April 10, 2012 /24-7PressRelease/
-- Psoriasis is a non-contagious, genetic disease of the immune system and manifests itself in the skin and/or joints of the body. It affects about 2% of the population or 7,500,000 people in the United States alone. Research is the top priority of The National Psoriasis Foundation, whose efforts are aimed at searching for better treatments and a cure for psoriasis.
"The National Psoriasis Foundation appreciates the dedication of our corporate partners who so willingly support our mission goal of research for a cure," says Eric Kimble, a Board of Trustee of the National Psoriasis Foundation and the Chairman of our Corporate Development Committee "We thank Mushatt's No. 9 for their support of our organization."
Mushatt's is especially pleased to play its part in helping find long-term solutions for the millions of sufferers of this debilitating disease, which very often has a significant impact on quality of life. The National Psoriasis Foundation's efforts have been a lone voice in advocating for support and Mushatts hopes that its contribution will be part of a growing movement to build greater awareness of Psoriasis and develop sustainable treatment solutions for this chronic skin disease," Michael Foley, President/CEO, Mushatt's LLC said today in Indialantic, Florida-home of the Mushatt's organization in the U.S.
Inspired and developed in Ireland in 1922, Mushatt's No. 9 range of skin care products include Psoriasis Skin Ointment, Psoriasis Facial Cream, Psoriasis Scalp Cream, and PsoriWash a non-detergent, non-soap, non-foaming wash formulated specifically for psoriasis sufferers. All the Mushatt's No. 9 psoriasis products are steroid free and are manufactured in the U.S. in an FDA-and GMP-registered state-of-the-art facility.
For more information about Mushatt's please visit: www.mushatts.com
; phone: 321-626-0600.